|Bid||0.0000 x 1100|
|Ask||0.0000 x 1100|
|Day's Range||3.7400 - 3.8400|
|52 Week Range||2.8800 - 4.7500|
|Beta (3Y Monthly)||0.78|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Represents Great Elm DME, Inc.’s first “tuck-in” acquisition pursuant to its strategic plan to meaningfully scale the business Expands operating footprint to three additional.
Great Elm Capital Group, Inc. generated $14.1 million of revenue and $3.9 million of adjusted EBITDA during the third quarter of 2019 DME business growth exceeded internal.
WALTHAM, Mass., May 03, 2019 -- Great Elm Capital Group, Inc. (NASDAQ: GEC, “Great Elm”) today announced plans to release its third quarter 2019 results on Friday, May 10, 2019.
NEW YORK, NY / ACCESSWIRE / February 11, 2019 / Great Elm Capital Group, Inc. (NASDAQ: GEC ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on February 11, 2019 ...
Great Elm’s respiratory-focused durable medical equipment business (“DME”) generated $13.2 million of revenue, $0.4 million of net income and $3.6 million of adjusted EBITDA in.
WALTHAM, Mass., Feb. 04, 2019 -- Great Elm Capital Group, Inc. (NASDAQ: GEC, “Great Elm”) today announced plans to release its second quarter 2019 results on Monday, February.
NEW YORK, Nov. 19, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
• VHG and NWM generated LTM Adjusted EBITDA of $14.1 million for the period ended 9/30/2018, representing 9.3% growth over LTM Adjusted EBITDA as of 6/30/2018• Platform poised.
WALTHAM, Mass., Nov. 02, 2018 -- Great Elm Capital Group, Inc. (NASDAQ: GEC, “Great Elm”) today announced plans to release its first quarter 2019 results on Friday, November 9,.